Provided by Morgan, Lewis & Bockius LLP
The intersection of business, science, and the law poses unique challenges for life sciences companies. Morgan Lewis understands the ramifications of that critical connection, and our lawyers work efficiently and strategically to solve the business, transactional, regulatory, intellectual property, litigation, and related issues our clients encounter throughout the product life cycle.
Our global life sciences capabilities were developed specifically to serve the pharmaceutical, biotechnology, medical device, and related industries, as well as the entities that invest in them, such as venture capital and private equity funds.
Provided by Chambers
Morgan Lewis regularly advises a client base of growing and mature life sciences companies on patent prosecution and commercialization agreements. It offers a nationally recognized pool of experts in litigation, transactional matters and regulatory matters through its extensive international network.
Steven Cohen, David Schwartz and Alan Leeds are key contacts.
Provided by Morgan, Lewis & Bockius LLP
Morgan, Lewis & Bockius represented Merck in its strategic collaboration with Orna Therapeutics, a biotechnology company pioneering a new investigational class of engineered RNA therapies.
Provided by Chambers
"I've been very pleased with the level of expertise, responsiveness and professionalism."
"They have an excellent bench and depth."
"I feel like I'm the most important client to all the attorneys I work with there. That's why I continue to go back."
"I've been very pleased with the level of expertise, responsiveness and professionalism."
"They have an excellent bench and depth."
"I feel like I'm the most important client to all the attorneys I work with there. That's why I continue to go back."